Does ELOSULFASE ALFA Cause Secretion discharge? 20 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 20 reports of Secretion discharge have been filed in association with ELOSULFASE ALFA (VIMIZIM). This represents 0.4% of all adverse event reports for ELOSULFASE ALFA.
20
Reports of Secretion discharge with ELOSULFASE ALFA
0.4%
of all ELOSULFASE ALFA reports
1
Deaths
6
Hospitalizations
How Dangerous Is Secretion discharge From ELOSULFASE ALFA?
Of the 20 reports, 1 (5.0%) resulted in death, 6 (30.0%) required hospitalization, and 1 (5.0%) were considered life-threatening.
Is Secretion discharge Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ELOSULFASE ALFA. However, 20 reports have been filed with the FAERS database.
What Other Side Effects Does ELOSULFASE ALFA Cause?
Pyrexia (682)
Cough (318)
Vomiting (308)
Malaise (282)
Headache (242)
Dyspnoea (216)
Nausea (212)
Pain (205)
Nasopharyngitis (183)
Fatigue (177)
What Other Drugs Cause Secretion discharge?
ADALIMUMAB (685)
DUPILUMAB (626)
ALBUTEROL (520)
OMALIZUMAB (514)
ETANERCEPT (487)
METHOTREXATE (387)
MEPOLIZUMAB (359)
BUDESONIDE\FORMOTEROL (339)
PREDNISONE (316)
SECUKINUMAB (307)
Which ELOSULFASE ALFA Alternatives Have Lower Secretion discharge Risk?
ELOSULFASE ALFA vs ELOTUZUMAB
ELOSULFASE ALFA vs ELOXATIN
ELOSULFASE ALFA vs ELRANATAMAB
ELOSULFASE ALFA vs ELRANATAMAB-BCMM
ELOSULFASE ALFA vs ELTROMBOPAG